Molecular profiling identifies new high-risk subtype of paediatric liver cancer
Until recently, nearly all pediatric liver cancers were classified as either hepatoblastoma or hepatocellular carcinoma.…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Until recently, nearly all pediatric liver cancers were classified as either hepatoblastoma or hepatocellular carcinoma.…
Ryan Layer, University of Colorado Boulder Most of the roughly 40 trillion cells of your…
Over the past decade, researchers have made great strides in the development and administration of…
Men taking either of the two most common oral medications for advanced prostate cancer who…
DNA mutations are essential to the rapid development of an array of antibody-producing immune cells…
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded…
Tumours from desmoplastic melanoma, a rare cancer most commonly found on the head or neck,…
Until recently, nearly all paediatric liver cancers were classified as either hepatoblastoma or hepatocellular carcinoma.…
Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome…
Cancer therapy increasingly relies on a personalised approach, where genetic changes in an individual tumour…